Literature DB >> 22262690

Neuromedin B and its receptor influence the activity of myometrial primary cells in vitro through regulation of Il6 expression via the Rela/p65 pathway in mice.

Wei-She Zhang1, Kui-Lin Fei, Mei-Ting Wu, Xin-Hua Wu, Qing-Hua Liang.   

Abstract

The neuromedin B receptor (Nmbr) is an important physiological regulator of spontaneous activities and stress responses through different cascades as well as its autocrine and paracrine effects. Previous studies have revealed that neuromedin B (Nmb) and its receptor signal via the Rela (also known as p65)/Il6 pathway in a mouse model of pregnancy. This study investigated the mechanism of Nmbr signaling via the Rela/p65-Il6 pathway and regulation of the concentration of intracellular free calcium ([Ca(2+)](i)) during the onset of labor in primary mouse myometrial cell cultures isolated from mice in term labor. Data demonstrated Nmbr agonist-mediated upregulation of the DNA binding activity of Rela/p65, Il6 expression, and [Ca(2+)](i) in a concentration-dependent manner. Furthermore, a significant correlation was observed between DNA binding activity of Rela/p65 and Il6 expression. Moreover, this up-regulation was blocked by Nmbr and Rela/p65 knockdown, achieved by RNA interference (RNAi) technology. No significant differences were identified in the inhibition of Il6 expression as a result of Nmbr or Rela/p65 knockdown. However, significant differences were observed between the [Ca(2+)](i) in Rela/p65-specific group and that in the Nmbr-specific small interfering RNA (siRNA)-treated groups. These data demonstrated that the Nmb/Nmbr interaction in pregnant myometrial primary cells in vitro predominantly influenced uterine activity through regulation of Il6 expression via the Rela/p65 pathway, although the effects of Nmbr on [Ca(2+)](i) involved several pathways that remain to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22262690     DOI: 10.1095/biolreprod.111.095984

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  6 in total

1.  Interaction between NF-κB and AP-1 and their intracellular localization at labor in human late pregnant myometrial cells in vivo and in vitro.

Authors:  Qiaozhen Peng; Yuelan Liu; Meilian Dong; Fang Xu; Jingrui Huang; Jingfei Chen; Xun Li; Jiejie Zhang; Weishe Zhang
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

2.  Role of neuromedin B and its receptor in the innate immune responses against influenza A virus infection in vitro and in vivo.

Authors:  Guihong Yang; Huipeng Huang; Mengyao Tang; Zifeng Cai; Cuiqin Huang; Baomin Qi; Ji-Long Chen
Journal:  Vet Res       Date:  2019-10-10       Impact factor: 3.683

3.  Genomic Analysis of Spontaneous Abortion in Holstein Heifers and Primiparous Cows.

Authors:  Kayleen F Oliver; Alexandria M Wahl; Mataya Dick; Jewel A Toenges; Jennifer N Kiser; Justine M Galliou; Joao G N Moraes; Gregory W Burns; Joseph Dalton; Thomas E Spencer; Holly L Neibergs
Journal:  Genes (Basel)       Date:  2019-11-21       Impact factor: 4.096

4.  Single-cell RNA sequencing reveals heterogeneity and differential expression of decidual tissues during the peripartum period.

Authors:  Jingrui Huang; Qi Li; Qiaozhen Peng; Yingming Xie; Weinan Wang; Chenlin Pei; Yanhua Zhao; Rong Liu; Lihui Huang; Tieping Li; Liangqun Xie; Jiejie Zhang; Lei Dai; Jingfei Chen; Jingchi Sun; Weishe Zhang
Journal:  Cell Prolif       Date:  2020-12-09       Impact factor: 6.831

5.  Neuromedin B mediates IL-6 and COX-2 expression through NF-κB/P65 and AP-1/C-JUN activation in human primary myometrial cells.

Authors:  Texuan Zhu; Jingfei Chen; Yanhua Zhao; Jiejie Zhang; Qiaozhen Peng; Jingrui Huang; Jiefeng Luo; Weishe Zhang
Journal:  Biosci Rep       Date:  2019-10-30       Impact factor: 3.840

6.  Neuromedin B receptor mediates neuromedin B-induced COX-2 and IL-6 expression in human primary myometrial cells.

Authors:  Jingfei Chen; Yun Shi; Jingrui Huang; Jiefeng Luo; Weishe Zhang
Journal:  J Investig Med       Date:  2020-07-21       Impact factor: 2.895

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.